The trading week begins with negative price developments not only on the Stockholm stock exchange but also in the rest of Europe. Also, the futures trading on the New York stock exchange indicates a weak opening in the afternoon.
This after President Donald Trump's statement over the weekend about introducing 30-percent import duties on EU goods from and including August 1.
At the same time, the reporting season has started quietly with, among other things, interim reports from Lifco and Hexatronic during the morning. The industrial conglomerate Lifco reports worse figures than expected and plummets over 9 percent.
The company, which made its debut on the OMXS30 list at the mid-year shift, is thus the absolute worst performer on the large company list. Another report loser is Inwido, which manufactures windows. The share backs down 9 percent after weaker order intake.
In the opposite direction, primarily the pharmaceutical giant Astra Zeneca is moving. During the morning, it was announced that they have achieved the primary goal in a phase 3 study with baxdrostat, a drug treatment for high blood pressure. The share rises almost 2 percent.
In the currency market, the US dollar has strengthened slightly and now costs 9.60 kronor.
